Ahmet Emin Ozturk

6PUBLICATIONS
55CO-AUTHORS
Predictive and prognostic markersAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 23, 2026
High TROP-2 expression as a predictor of poor neoadjuvant chemotherapy response in luminal B breast cancer: a retrospective clinicopathological study.

|Apr 29, 2026
Evaluation of hepatitis B virus screening and reactivation in patients with hematological malignancies receiving rituximab-based chemoimmunotherapy: A single-center retrospective study.

|Aug 27, 2025
Bevacizumab Efficacy and Tolerability in Patients with Metastatic Platinum-Sensitive Ovarian Cancer Beyond Progression.

Mert Erciyestepe, Şermin Dinç Sonuşen, Şaban Seçmeler

|Jul 12, 2025
First-Line Chemotherapy Versus CDK4/6 Inhibitors in HR-Positive, HER2-Negative Breast Cancer with Liver Metastases: A Multicenter Real-World Data.

Mehmet Cem Fidan, Ahmet Emin Öztürk, Okan Aydın

|Nov 15, 2024
Assessing the Impact of Serum Calcium, 25-Hydroxy Vitamin D, Ferritin, and Uric Acid Levels on Colorectal Cancer Risk.

Abdulbari Bener, Ahmet Emin Ozturk, Unsal Veli Ustundag

|Jul 01, 2024
Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group.

Arif Akyildiz, Melis Gultekin, Ecem Yigit

Pageof 1

Frequent Collaborators

2 joint publications

Okan Aydın

2 joint publications

Nargiz Majidova

2 joint publications

Rumeysa Colak

2 joint publications

Mesut Yılmaz